AbbVie tokenized stock (xStock) PriceABBVX

What is AbbVie tokenized stock (xStock) (ABBVX)?

AbbVie tokenized stock (xStock) (ABBVX) is a blockchain-based tokenized tracker certificate that provides economic exposure to the common stock of AbbVie Inc. (ticker: ABBV), a pharmaceutical company listed on the NYSE. Issued by Backed Assets (JE) Limited, ABBVX is part of the broader xStocks product suite, which was created to remove barriers to investing by offering tokenized stocks that are backed 1:1 by underlying assets, composable with DeFi protocols, and compliant with EU regulations. Each ABBVX token is backed 1-1 by real AbbVie Inc. shares held by a third-party custodian, giving eligible non-US users regulatory-compliant access to AbbVie's stock price. The token is deployed on Solana and also exists as an ERC-20 token on Arbitrum. ABBVX launched on Sept. 18, 2025, and is designed for 24/5 trading with fractional investment options starting as low as $1 per xStock. The native ABBVX token has a circulating supply of approximately 1,011 tokens, while its wrapped variant, WABBVX, is a non-rebasing token intended for DeFi applications. The project represents an early-stage tokenized equity product within the growing real-world asset (RWA) sector.

Key Specifications & Tokenomics

• Name: AbbVie tokenized stock (xStock)
• Ticker / Symbol: ABBVX
• Trading Pair: ABBVX/USD (also referenced as ABBVX-USD)
• CMC ID: 37011
• UCID: 37272 (for the wrapped variant, WABBVX)
• Underlying Asset: Common stock of AbbVie Inc. (ticker: ABBV), listed on NYSE
• Issuer: Backed Assets (JE) Limited
• Instrument Type: Tokenized tracker certificate providing economic exposure to the common stock of AbbVie Inc. (ABBV)
• Blockchain / Platform: Solana; also deployed on Arbitrum as an ERC-20 token
• Contract Address (ERC-20 on Arbitrum): 0xfbf2398df672cee4afcc2a4a733222331c742a6a
• Start Date: Sept. 18, 2025
• Official Website: https://assets.backed.fi/products/abbvie-xstock
• Twitter / X: https://twitter.com/xStocksFi
• Tags: Tokenized Assets, Tokenized Stock, DeFi
• Circulating Supply: Approximately 1,011 ABBVX
• Total Supply: Approximately 389,210 – 393,215 ABBVX (varies by source)
• Max Supply: 0 ABBVX (as reported by Bitget)
• Market Cap: Approximately $256,927 – $265,515
• Fully Diluted Market Cap / FDV: Approximately $96.86M – $103.23M
• Vol/Market Cap (24hr): 42.23%
• Wrapped Variant (WABBVX) Total Supply: 0 WABBVX

Who created AbbVie tokenized stock (xStock)?

AbbVie tokenized stock (xStock) (ABBVX) is issued by Backed Assets (JE) Limited, the entity behind the xStocks product line. The xStocks initiative was developed to provide tokenized exposure to US stocks and ETFs, with a focus on regulatory compliance and accessibility for non-US users. The official xStocks communication channels include a website at assets.backed.fi and a Twitter/X account at xStocksFi. While the issuer entity is identified, detailed public information about the specific founding team, individual developers, or corporate leadership behind Backed Assets (JE) Limited is currently limited in the available materials. The project operates under EU regulatory frameworks and partners with third-party custodians to hold the underlying AbbVie Inc. shares. Kraken is a prominent platform offering xStocks trading, though it is not a party to the custody agreement. The project's development and operational structure remain centered around the xStocks ecosystem, which encompasses 57 US stocks and ETFs.

How does AbbVie tokenized stock (xStock) work?

ABBVX functions as a tokenized tracker certificate that mirrors the price of AbbVie Inc. common stock. Each ABBVX digital token is backed 1-1 by real AbbVie Inc. shares, which are held by a third-party custodian under a custody agreement. When a user purchases ABBVX, they gain indirect exposure to the price movements of AbbVie stock without holding the actual shares. The token can be traded 24/5, providing continuous market access during weekdays in eligible geographies. Fractional trading is supported, allowing investments starting from as low as $1 per xStock. Users can buy ABBVX using cryptocurrency, stablecoins, or USD, and tokens can be withdrawn to any compatible on-chain wallet. The wrapped variant, WABBVX, is a non-rebasing token that enables integration with DeFi applications. Importantly, holding ABBVX does not confer shareholder rights, nor does it entitle holders to receive company information or dividends directly. The underlying shares are fully collateralized and secured by regulated third-party depositary institutions. The token operates on Solana and Arbitrum, leveraging blockchain infrastructure for transparency and composability with DeFi protocols.

What makes AbbVie tokenized stock (xStock) unique and valuable?

ABBVX offers several distinctive features that differentiate it from traditional stock ownership and other crypto assets. First, it provides 24/5 trading access to AbbVie stock exposure, which is more flexible than conventional market hours. Second, it enables fractional ownership, lowering the barrier to entry with investments starting at just $1. Third, it is backed 1:1 by real AbbVie shares held by a regulated third-party custodian, offering a legal claim to the value of the stock. Fourth, ABBVX is composable with DeFi protocols, meaning it can be integrated into various decentralized finance applications like any other token, especially through its wrapped variant WABBVX. Fifth, it is compliant with EU regulations and accessible to non-US users, providing a regulatory-compliant pathway to US stock exposure. Sixth, xStocks as a whole enable easy access to 57 US stocks and ETFs, positioning ABBVX within a broader ecosystem of tokenized real-world assets. Finally, the ability to purchase using crypto, stablecoins, or USD, and to withdraw to compatible on-chain wallets, adds flexibility and self-custody options that traditional brokerage accounts may not offer.

What is AbbVie tokenized stock (xStock) used for?

ABBVX is primarily used to gain economic exposure to the price movements of AbbVie Inc. common stock without directly owning the underlying shares. It serves as a tool for eligible non-US investors who seek access to US equity markets through blockchain-based tokens. The token can be traded on supported platforms, used as collateral or within DeFi protocols via its wrapped variant WABBVX, and held in compatible on-chain wallets for self-custody. It also enables portfolio diversification by allowing crypto-native investors to include traditional pharmaceutical stock exposure within their digital asset holdings. Additionally, ABBVX can be purchased with various payment methods, including Bitcoin (BTC), stablecoins, or USD, making it accessible to users with different asset preferences. The token supports fractional investment, making it suitable for retail investors who wish to gain exposure to AbbVie with small capital. It is designed for 24/5 trading, providing flexibility for investors across different time zones. Finally, ABBVX serves as a building block for more complex DeFi strategies, such as yield farming or liquidity provision, when used in its wrapped form.

How Is the AbbVie tokenized stock (xStock) ecosystem developing?

The xStocks ecosystem, which includes ABBVX, is developing as part of the broader tokenized real-world asset (RWA) sector. According to CoinGecko, tokenized stock volume has approached $3 billion, indicating growing market interest in this category. The xStocks platform supports 57 US stocks and ETFs, and ABBVX is one of several tokenized equities available alongside assets like Nvidia (NVDA), Apple (AAPL), Alphabet (GOOGL), Microsoft (MSFT), Amazon (AMZN), Tesla (TSLA), and others. The wrapped variant WABBVX is specifically designed for DeFi integration, allowing the token to be used within decentralized applications without rebasing. xStocks are available on multiple trading venues and data platforms, including Kraken, Binance, Bitget, Bybit, CoinGecko, CoinMarketCap, Investing.com, and Yahoo Finance. The project emphasizes regulatory compliance with EU regulations and accessibility for non-US users. As the tokenized stock sector evolves, ABBVX's ecosystem development is tied to the expansion of xStocks' product offerings, DeFi composability, and the increasing adoption of blockchain-based traditional asset exposure. The introduction of WABBVX further supports ecosystem growth by enabling DeFi use cases.

How to mine AbbVie tokenized stock (xStock)?

ABBVX is not a mined cryptocurrency. It is a tokenized tracker certificate backed by real AbbVie Inc. shares held by a third-party custodian. There is no mining process, proof-of-work, or proof-of-stake consensus mechanism associated with ABBVX itself. Instead, the token is issued by Backed Assets (JE) Limited and represents a 1:1 claim on the underlying shares. Users acquire ABBVX by purchasing it on supported platforms using crypto, stablecoins, or USD. The token can be withdrawn to compatible on-chain wallets. The wrapped variant, WABBVX, is created by wrapping ABBVX and does not involve mining. There is no staking mechanism native to ABBVX, although the token may be used within DeFi protocols for activities like liquidity provision or yield farming, depending on third-party platform support. Therefore, traditional mining or staking does not apply to ABBVX; acquisition is solely through market purchase or issuance mechanisms provided by the xStocks platform.

How to keep your AbbVie tokenized stock (xStock) safe?

To keep ABBVX safe, users should follow standard cryptocurrency security practices. First, store ABBVX in a compatible on-chain wallet that supports Solana or Arbitrum networks, depending on the token variant. Second, use hardware wallets for long-term storage to protect private keys from online threats. Third, enable two-factor authentication (2FA) on any exchange account used to purchase or trade ABBVX. Fourth, verify contract addresses before interacting with any token, ensuring the correct ABBVX or WABBVX contract is used. Fifth, be cautious of phishing attempts and only use official websites and links, such as the Backed Assets product page and the official xStocks Twitter account. Sixth, keep software wallets and applications updated to the latest versions to mitigate vulnerabilities. Seventh, consider the risks outlined by Bitget: the value of ABBVX is not widely recognized by the market, and like all cryptocurrency investments, prices can be volatile. Eighth, remember that holding ABBVX does not confer shareholder rights, and the token provides indirect exposure only. Finally, for DeFi interactions with WABBVX, audit smart contract risks and use reputable protocols to minimize exposure to hacks or exploits.